BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform. The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and employers. Clients will be able to offer their members access to a suite of cardiometabolic care, including obesity, diabetes prevention and management, and behavioral health support. The program will tailor care based on social factors such as food security, financial barriers, cultural norms, and beliefs. Vida’s services are available on the Amwell platform alongside existing virtual primary care, urgent care, behavioral health and other clinical programs in the Amwell ecosystem. “We are thrilled to partner with Amwell,” said Joe Murad, CEO of Vida Health. “By leveraging our complementary capabilities, we’re making it easier than ever to provide members with personalized, high-touch care. Together, we’re working to reduce member friction, improve health outcomes at scale, and reduce costs.” More than 40 percent of American adults struggle with obesity, a condition that increases the risk of developing diabetes, heart disease and cancer. Together, obesity and diabetes cost the U.S. healthcare system more than $500 billion a year. Vida clinicians prescribe GLP-1s, other anti-obesity medications and lifestyle interventions like Medical Nutrition Therapy. These services are delivered through a value-based, outcomes-driven model that ensures accountability and measurable results. “We’re pleased Vida is joining the growing number of third-party programs available through Amwell’s integrated clinical solutions portfolio. With this partnership, our health plan clients can offer members a single entry point to the clinical and behavioral health support they need for obesity care and related illnesses,” said Ido Schoenberg, Amwell chairman and CEO. “Vida’s programs adapt to the patient’s needs, resulting in a personalized, cost-effective way to achieving weight loss requirements while applying an evidence-based, step therapy approach.” Amwell’s clinical programs portfolio features virtual and digital care products from partners addressing various health conditions. The portfolio is part of the company’s platform and provides health plans with the technology to offer employers and members a unified and delightful entry point to a comprehensive and dynamic set of orchestrated clinical programs. The result is a personalized and reportable whole-person care model focused on improving health outcomes and driving efficiencies. About Vida Health Vida Health is a virtual obesity and metabolic center of excellence that provides personalized care for individuals with obesity and related conditions. Vida’s holistic approach combines human care with AI-powered insights to deliver lasting health outcomes and help prevent and manage chronic diseases. Vida serves members in all 50 states, offering services in both English and Spanish, and operates on a value-based pricing model, putting outcomes at the center of care. To learn more, visit www.Vida.com. About Amwell Amwell is a leading hybrid care delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visithttps://business.amwell.com/. ©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell logo are registered trademarks or trademarks of American Well Corporation.
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...